gamma-glutamyl-s-(benzyl)-cysteinyl-r(-)-phenylglycine diethyl ester

Small moleculeexperimental

Clinical trial activity

8 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
7
Phase 3
0
Phase 4
0

Earliest trial started Apr 1, 2002 (NCT00035867)

Timeline

2000s

  1. Jan 1, 2002

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2008

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@@H](C(=O)OCC)c1ccccc1
Mol. weight
529.66 g/mol
Lipinski Ro5
1 violation(s)
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • ezatiostat
  • ezatiostat
  • ezatiostat
  • ezatiostat hcl
  • ezatiostat hcl
  • ezatiostat hydrochloride
  • ezatiostat hydrochloride
  • ezatiostat hydrochloride
  • ezatiotsat
  • gamma-glu-s-bzcys-phgly diethyl ester
  • gamma-glutamyl-s-(benzyl)cysteinyl-phenylglycine diethyl ester
  • gamma-glutamyl-s-(benzyl)-cysteinyl-r(-)-phenylglycine diethyl ester
  • gamma-glutamyl-s-(benzyl)-cysteinyl-r(-)-phenylglycine diethyl ester
  • t.199
  • telintra
  • telintra
  • telintra
  • ter199
  • ter199
  • ter 199
  • ter-199
  • tlk117
  • tlk 117
  • tlk-117
  • tlk199
  • tlk199
  • tlk199
  • tlk199
  • tlk 199
  • tlk-199

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01459159Phase 2Oct 1, 2011Telik
NCT01422486Phase 2Oct 1, 2011Telik
NCT01062152Phase 1Nov 1, 2009Telik
NCT00909584Phase 2Apr 1, 2009Telik
NCT00701870Phase 2Oct 1, 2008Telik
NCT00700206Phase 2May 1, 2008Telik
NCT00280631Phase 1/Phase 2 (Phase 2)Feb 1, 2006Telik
NCT00035867Phase 1/Phase 2 (Phase 2)Apr 1, 2002Telik
Showing 8 of 8 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
TelikFor profit8822002
1 organizations
Page 1 / 1